Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Sandra Rivera's research has focused on the development of live attenuated bacterial vaccines for cancer immunotherapy, primarily utilizing *Listeria monocytogenes* as a vector. Her work includes the construction and characterization of attenuated strains designed for clinical use in treating various cancers, particularly those overexpressing Her2/neu. Rivera has investigated the ability of these engineered bacteria to elicit potent T-cell responses and impact tumor growth. Her publications also extend to the molecular epidemiology of *Candida auris* in Colombia, examining regional patterns in antifungal resistance. Rivera's scholarly contributions are reflected in her h-index of 16, with over 61 publications and 1,010 citations.
Metrics
- h-index: 16
- Publications: 61
- Citations: 1,010
Positions
-
Docente 2015–presentUniversidad Santiago de Cali Valle ORCID
-
DocenteUniversity of Arkansas at Fayetteville ORCID
Selected Publications
-
Considering Bulk Data Centers in Hybrid AC/DC Transmission Network Expansion Planning (2025)
Collaboration Network
Top Collaborators
- Considering Bulk Data Centers in Hybrid AC/DC Transmission Network Expansion Planning
- Considering Bulk Data Centers in Hybrid AC/DC Transmission Network Expansion Planning
- Considering Bulk Data Centers in Hybrid AC/DC Transmission Network Expansion Planning
Similar Researchers
Based on overlapping research topics